<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-0AZHIHFV</identifier><date>2018</date><creator>Debeljak, Nataša</creator><creator>Fecková, Barbora</creator><creator>Kimáková, Patrícia</creator><creator>Solár, Peter</creator><creator>Szentpéteriová, Erika</creator><relation>documents/doc/0/URN_NBN_SI_doc-0AZHIHFV_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-0AZHIHFV_001.txt</relation><format format_type="issue">4</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 842-846</format><identifier identifier_type="ISSN">1580-3155</identifier><identifier identifier_type="COBISSID">34117081</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-0AZHIHFV</identifier><language>eng</language><publisher>Slovensko kemijsko društvo</publisher><source>Acta chimica slovenica</source><rights>BY</rights><subject language_type_id="slv">eritropoetin</subject><subject language_type_id="slv">rakave celice</subject><subject language_type_id="slv">receptor za eritropoetin</subject><subject language_type_id="slv">tamoxifen</subject><title>Erythropoietin potentiates the anti-proliferative effect of tamoxifen in ovarian adenocarcinoma A2780 cells</title></Record>